Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.

@article{Vittengl2014StableRA,
  title={Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.},
  author={Jeffrey R Vittengl and Lee Clark and Michael E. Thase and Robin B. Jarrett},
  journal={Journal of consulting and clinical psychology},
  year={2014},
  volume={82 6},
  pages={1049-59}
}
OBJECTIVE Continuation-phase cognitive therapy (C-CT) or fluoxetine (FLX) reduces relapse in adults with major depressive disorder (MDD; Jarrett, Minhajuddin, Gershenfeld, Friedman, & Thase, 2013). Among patients at higher risk for relapse, we hypothesized that continuation-phase treatment reduces residual symptoms and facilitates stable remission and recovery. METHOD Outpatients (N = 241) with recurrent MDD who responded to acute-phase CT with higher risk for relapse (i.e., had unstable… CONTINUE READING